CLINICAL PHARMACOKINETIC EQUATIONS AND CALCULATIONS ONECOMPARTMENT MODEL EQUATIONS

  • Slides: 29
Download presentation
CLINICAL PHARMACOKINETIC EQUATIONS AND CALCULATIONS

CLINICAL PHARMACOKINETIC EQUATIONS AND CALCULATIONS

ONE-COMPARTMENT MODEL EQUATIONS FOR LINEAR PHARMACOKINETICS

ONE-COMPARTMENT MODEL EQUATIONS FOR LINEAR PHARMACOKINETICS

Intravenous Bolus Equation C= −ket (D/V)e • t= time after the intravenous bolus was

Intravenous Bolus Equation C= −ket (D/V)e • t= time after the intravenous bolus was given • (t = 0 at the time the dose was administered), • C is the concentration at time = t, • V is the volume of distribution, • ke is the elimination rate constant.

1) A patient is given a theophylline loading dose of 400 mg intravenously over

1) A patient is given a theophylline loading dose of 400 mg intravenously over 20 minutes, volume of distribution is 30 L, the elimination rate constant equals 0. 115 h-1. compute the expected theophylline concentration 4 hours after the dose was given. • t 1/2 = 0. 693/ke = 0. 693/0. 115 h-1 =6 h • C = (D/V)e−ket = (400 mg/30 L)e −(0. 115 h)(4 h) = 8. 4 mg/L

Distribution phase & Elimination phase

Distribution phase & Elimination phase

2) A patient is given an intravenous dose of vancomycin 1000 mg. the volume

2) A patient is given an intravenous dose of vancomycin 1000 mg. the volume of distribution equals 50 L, the elimination rate constant is 0. 077 h− 1, calculate the expected vancomycin concentration 12 hours after the dose was given. • t 1/2 = 0. 693/ke = 0. 693/0. 077 h− 1 = 9 h • C = (D/V)e −ket = (1000 mg / 50 L) e−(0. 077 h− 1)(12 h) = 7. 9 mg/L

Pharmacokinetic parameters for patients can also be computed for use in the equations. The

Pharmacokinetic parameters for patients can also be computed for use in the equations. The elimination rate constant, half-life and volume of distribution can be calculated

3) A patient was given an intravenous loading dose of phenobarbital 600 mg over

3) A patient was given an intravenous loading dose of phenobarbital 600 mg over a period of about an hour. One day and four days after the dose was administered phenobarbital serum concentrations were 12. 6 mg/L and 7. 5 mg/L, respectively 1. t 1/2 is determined by measuring the time needed for serum concentrations to decline by 1/2 2. ke = 0. 693/t 1/2 = 0. 693/4 d = 0. 173 d− 1 3. The concentration/time line can be extrapolated to the concentration axis to derive the concentration at time zero (C 0 = 15 mg/L) 4. volume of distribution V = D/C 0 = 600 mg/ (15 mg/L) = 40 L

ke = −(ln C 1 − ln C 2)/(t 1 − t 2) t

ke = −(ln C 1 − ln C 2)/(t 1 − t 2) t 1 and C 1 are the first time/concentration pair Alternatively t 2 and C 2 are the second time/concentration pair ke=−[ln(12. 6 mg/L) − ln(7. 5 mg/L)]/(1 d − 4 d) t 1/2 = 0. 693/ke = 0. 173 d− 1 = 0. 693/0. 173 d− 1 =4 d C 0 = C/e −ket = (12. 6 mg / L) / e−(0. 173 d− 1)(1 d) = 15. 0 mg/L V = D/C 0 = 600 mg / (15 mg/L) = 40 L

Continuous and Intermittent Intravenous Infusion Equations

Continuous and Intermittent Intravenous Infusion Equations

If infusion is running -ket CC==(k(k 0/Cl)(1 -e-ket)) = [k 0/(ke. V)](1 – e-ket)

If infusion is running -ket CC==(k(k 0/Cl)(1 -e-ket)) = [k 0/(ke. V)](1 – e-ket) • • k 0 is the drug infusion rate (amount per unit time, mg/h or μg/min), Cl = ke. V, this substitution was made in the second version of the equation), ke is the elimination rate constant, t is the time that the infusion has been running. Css = k 0 / Cl = k 0 / (ke. V)

If the infusion is stopped • Cpostinfusion = Cende−ketpostinfusion • t post infusion is

If the infusion is stopped • Cpostinfusion = Cende−ketpostinfusion • t post infusion is the post infusion time (t post infusion = 0 at end of infusion and increases from that point).

4) A patient is administered 60 mg/h of theophylline, V = 40 L and

4) A patient is administered 60 mg/h of theophylline, V = 40 L and ke = 0. 139 h− 1. calculate The serum concentration of theophylline in this patient after receiving the drug for 8 hours and at steady state. C = [k 0/(ke. V)](1 − e−ket) = [(60 mg/h)/(0. 139 h− 1 ⋅ 40 L)](1 − e−(0. 139 h− 1)(8 h)) = 7. 2 mg/L Css = k 0/(ke. V) = (60 mg/h)/(0. 139 h− 1 ⋅ 40 L) = 10. 8 mg/L

Continue… compute theophylline serum concentration 6 hours after the infusion stopped • If the

Continue… compute theophylline serum concentration 6 hours after the infusion stopped • If the infusion only ran for 8 hours, Cpostinfusion = Cend e −ke tpostinfusion = (7. 2 mg/L) e−(0. 139 h− 1)(6 h) = 3. 1 mg/L • If the infusion ran until steady state was achieved, Cpostinfusion = Cend e −ke tpostinfusion = (10. 8 mg/L) e−(0. 139 h− 1)(6 h) = 4. 7 mg/L

5) A patient was given a single 120 -mg dose of tobramycin as a

5) A patient was given a single 120 -mg dose of tobramycin as a 60 -minute infusion, and concentrations at the end of infusion (6. 2 mg/L) and 4 hours after the infusion ended (1. 6 mg/L) were obtained. 1 - t 1/2 can be determined by measuring the time it takes for serum concentrations to decline by one-half = 2 hr 2 - ke = 0. 693/t 1/2 = 0. 693/2 h = 0. 347 h− 1

Or without a plot 1 - ke = −(ln C 1− ln C 2)/(t

Or without a plot 1 - ke = −(ln C 1− ln C 2)/(t 1 − t 2) = −[ln (6. 2 mg/L) − ln (1. 6 mg/L)] / (1 h − 5 h) =0. 339 h− 1 2 - t 1/2 = 0. 693/ke = 0. 693/0. 339 h− 1 =2 h

The volume of distribution (V) Can be computed using the following equations: • At

The volume of distribution (V) Can be computed using the following equations: • At steady state and when we know C 0 V= V= Dose // C C 00 or or V= V= Cl/K • in I. V infusion or before steady state -ket’)] [k 0(1 -e-ket’ )] / k e [Cmax-(Cpredose e -ket’ [k 0(1 -e )] / ke[Cmax-(Cpredose e )]

Extravascular Equation The absorption rate constant describes how quickly drug is absorbed with a

Extravascular Equation The absorption rate constant describes how quickly drug is absorbed with a large number indicating fast absorption and a small number indicating slow absorption

Extravascular Equation C = {(Fka. D) / [V(ka − ke)]}(e−ket − e−kat) F is

Extravascular Equation C = {(Fka. D) / [V(ka − ke)]}(e−ket − e−kat) F is the bioavailability fraction, ka is the absorption rate constant, D is the dose

example • 500 mg of oral procainamide -----D • a half-life equal to 4

example • 500 mg of oral procainamide -----D • a half-life equal to 4 hours ----- t 1/2 • an elimination rate constant of 0. 173 h− 1 ---- ke • volume of distribution of 175 L ----- V • absorption rate constant equal to 2 h− 1 ------ ka • oral bioavailability fraction of 0. 85 ----- F C = {(Fka. D) / [V(ka − ke)]}(e −ket − e −kat)

After the end of absorption phase the C can be calculated by equation of

After the end of absorption phase the C can be calculated by equation of I. V bolus C = [(FD)/V]e −ket • C is the concentration at any post absorption, post distribution time

The hybrid volume of distribution/bioavailability (V/F) parameter Since volume of distribution relate the dose

The hybrid volume of distribution/bioavailability (V/F) parameter Since volume of distribution relate the dose given with the obtained concentration and since in extravascular route not all the dose enter the blood stream so we use (V/F) to indicate the value of volume of distribution • V/F = D/C 0……………. or • V = D/ [C 0 − Cpredose], if not first dose • C 0 = C/e −ket • Ke = − (ln C 1 − ln C 2) / (t 1 − t 2)

6) An oral dose of valproic acid 750 mg as capsules. 6 and 24

6) An oral dose of valproic acid 750 mg as capsules. 6 and 24 hours after the dose, the valproic acid serum concentrations are 51. 9 mg/L and 21. 3 mg/L, respectively. • After graphing the serum concentration/time data--- • ke = 0. 693 / t 1/2 = 0. 693/14 h---ke = 0. 0495 h− 1 • At time = 0 ----- (C 0 = 70 mg/L) • hybrid volume of distribution/bioavailability V/F = D/C 0 = 750 mg/70 L = 10. 7 L t 1/2=14 hours

Alternatively ke = −(ln C 1 − ln C 2)/(t 1 − t 2)

Alternatively ke = −(ln C 1 − ln C 2)/(t 1 − t 2) t 1/2 = 0. 693/ke C 0 = C/e −ket V = D/C 0

Multiple-Dose and Steady-State Equations • change a single dose equation to the multiple dose

Multiple-Dose and Steady-State Equations • change a single dose equation to the multiple dose version, • multiply each exponential term in the equation by the multiple dosing factor: (1 − e−nkiτ)/(1 − e−kiτ) n is the number of doses administered, ki is the rate constant, τ is the dosage interval.

At steady state • number of doses (n) is large, • the exponential term

At steady state • number of doses (n) is large, • the exponential term in the numerator of the multiple dosing factor (−nkiτ) becomes a large negative number-------exponent approaches zero. • Therefore, the steady-state version of the multiple dosing factor • becomes the following: 1/(1 − e−kiτ)

Multiple-Dose and Steady-State Equations C= −ket (D/V)e C = (D/V)[e−ket/ (1 − e −keτ)]

Multiple-Dose and Steady-State Equations C= −ket (D/V)e C = (D/V)[e−ket/ (1 − e −keτ)]

To be continued….

To be continued….